Neufeld Leah R 4
4 · Immuneering Corp · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
Immuneering (IMRX) CPO Leah Neufeld Buys 3,628 Shares via ESPP
What Happened
Leah Neufeld, Chief People Officer of Immuneering Corporation (IMRX), acquired 3,628 shares of Class A common stock on March 13, 2026 at $4.29 per share, for a total purchase value of $15,573. The acquisition was made through the company's 2021 Employee Stock Purchase Plan (ESPP) and is reported as an acquisition (transaction code A).
Key Details
- Transaction date: March 13, 2026 (Purchase Date under the ESPP).
- Price: $4.29 per share; total value $15,573.
- Shares owned after transaction: Not disclosed in the Form 4 filing.
- Footnotes:
- F1: Reported voluntarily under the Immuneering 2021 ESPP; exempt under Rule 16b-3(c).
- F2: Offering period ran Sept 16, 2025 – Mar 15, 2026; purchase occurred on the Purchase Date of Mar 13, 2026.
- F3: Shares purchased at no less than 85% of the fair market value on the Purchase Date (ESPP discount).
- Filing timeliness: Form 4 filed on Mar 17, 2026, within the typical 2-business-day SEC filing window for Section 16 insiders.
Context
This was an ESPP purchase—employees often buy shares at a discounted price (here, at least a 15% discount to FMV). Such purchases are routine employee compensation/benefit transactions and can be interpreted as an insider acquiring stock, though the purchase size here (~$15.6k) is modest. The filing notes the transaction is exempt under Rule 16b-3(c), which commonly covers compensatory stock plans.
Insider Transaction Report
- Award
Class A Common Stock
[F1][F2][F3]2026-03-13$4.29/sh+3,628$15,573→ 29,598 total
Footnotes (3)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's Class A Common Stock pursuant to the Immuneering Corporation 2021 Employee Stock Purchase Plan (the "ESPP"), for the ESPP purchase period of September 16, 2025 through March 15, 2026. This transaction is also exempt pursuant to Rule 16b-3(c) promulgated pursuant to the Securities Exchange Act of 1934.
- [F2]The relevant Offering Period (as defined in the ESPP) ended on March 15, 2026. The shares were acquired on the Purchase Date (as defined in the ESPP) of March 13, 2026.
- [F3]In accordance with the ESPP, the shares were purchased at a price not less than eighty-five percent (85%) of the Fair Market Value (as defined in the ESPP) of a share of Class A Common Stock on the Purchase Date of the relevant Offering Period.